Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro.
Saved in:
| Title: | Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro. |
|---|---|
| Authors: | Harfoot R; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Lawley B; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Hernández LC; Department of Pediatric Dentistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Kuang J; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.; School of Biomedical Sciences, Victoria University of Wellington, Wellington, New Zealand., Hills FR; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Sinha S; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Allais MJM; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.; Institute of Environmental Science and Research, Wellington, New Zealand., Bird TW; School of Biomedical Sciences, Victoria University of Wellington, Wellington, New Zealand., Hird CP; Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, London, Ontario, Canada., Taylor JA; School of Biological Sciences, The University of Auckland, Auckland, New Zealand., Bostina M; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Comoletti D; School of Biomedical Sciences, Victoria University of Wellington, Wellington, New Zealand., Haney EF; Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada., Hancock REW; Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada., Pletzer D; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Quiñones-Mateu ME; Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, London, Ontario, Canada. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Aug 06; Vol. 69 (8), pp. e0170024. Date of Electronic Publication: 2025 Jun 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
